NO984166L - Sekvenskombinasjon av °strogen/progesteronantagonister for hormonerstatningsterapi - Google Patents

Sekvenskombinasjon av °strogen/progesteronantagonister for hormonerstatningsterapi

Info

Publication number
NO984166L
NO984166L NO984166A NO984166A NO984166L NO 984166 L NO984166 L NO 984166L NO 984166 A NO984166 A NO 984166A NO 984166 A NO984166 A NO 984166A NO 984166 L NO984166 L NO 984166L
Authority
NO
Norway
Prior art keywords
replacement therapy
hormone replacement
estrogen
sequence combination
progesterone antagonists
Prior art date
Application number
NO984166A
Other languages
English (en)
Other versions
NO324613B1 (no
NO984166D0 (no
Inventor
Kristof Chwalisz
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO984166L publication Critical patent/NO984166L/no
Publication of NO984166D0 publication Critical patent/NO984166D0/no
Publication of NO324613B1 publication Critical patent/NO324613B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
NO19984166A 1996-03-11 1998-09-10 Anvendelse av en sekvenskombinasjon av ostrogen/progesteronantagonister for fremstilling av et legemiddel for hormonerstatningsterapi NO324613B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19610635A DE19610635A1 (de) 1996-03-11 1996-03-11 Sequentielle Estrogen/Progesteronantagonist-Kombination für die Hormonersatz-Therapie
PCT/DE1997/000580 WO1997033589A1 (de) 1996-03-11 1997-03-11 Sequentielle estrogen/progesteronantagonist-kombination für die hormonersatz-therapie

Publications (3)

Publication Number Publication Date
NO984166L true NO984166L (no) 1998-09-10
NO984166D0 NO984166D0 (no) 1998-09-10
NO324613B1 NO324613B1 (no) 2007-11-26

Family

ID=7788657

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19984166A NO324613B1 (no) 1996-03-11 1998-09-10 Anvendelse av en sekvenskombinasjon av ostrogen/progesteronantagonister for fremstilling av et legemiddel for hormonerstatningsterapi

Country Status (16)

Country Link
EP (1) EP0889727B1 (no)
JP (1) JP2000506175A (no)
KR (1) KR19990087672A (no)
AT (1) ATE319454T1 (no)
AU (1) AU2691197A (no)
BR (1) BR9708162A (no)
CA (1) CA2248841C (no)
DE (2) DE19610635A1 (no)
DK (1) DK0889727T3 (no)
ES (1) ES2260792T3 (no)
HU (1) HUP9901474A3 (no)
IL (1) IL126176A (no)
NO (1) NO324613B1 (no)
PL (1) PL328809A1 (no)
PT (1) PT889727E (no)
WO (1) WO1997033589A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19834931A1 (de) * 1998-07-28 2000-02-24 Jenapharm Gmbh Verwendung von biogenen Estrogenen zur Hormonsubstitutionstherapie
US7629334B1 (en) 1999-08-31 2009-12-08 Bayer Schering Pharma Aktiengesellschaft Mesoprogrestins (progesterone receptor modulations) as a component of compositions for hormone replacement therapy (HRT)
IL148417A0 (en) * 1999-08-31 2002-09-12 Jenapharm Gmbh Mesoprogestins (progesterone receptor modulators) as a component of compositions for hormone replacement therapy (hrt)
IL145838A (en) * 2000-10-16 2008-11-03 Pfizer Prod Inc Use of an estrogen agonist / antagonist to produce a drug for the treatment of vaginitis
ES2233570T3 (es) * 2000-11-30 2005-06-16 Pfizer Products Inc. Composicion que contiene agonistas/antagosnistas de estrogenos y testosterona para tratar un descenso en el nivel de la hormona testosterona.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5468736A (en) * 1993-02-25 1995-11-21 The Medical College Of Hampton Road Hormone replacement therapy

Also Published As

Publication number Publication date
AU2691197A (en) 1997-10-01
ATE319454T1 (de) 2006-03-15
BR9708162A (pt) 1999-07-27
DE19610635A1 (de) 1997-09-18
DK0889727T3 (da) 2006-07-03
HUP9901474A2 (hu) 1999-09-28
CA2248841A1 (en) 1997-09-18
ES2260792T3 (es) 2006-11-01
PL328809A1 (en) 1999-02-15
KR19990087672A (ko) 1999-12-27
IL126176A (en) 2004-12-15
NO324613B1 (no) 2007-11-26
DE59712593D1 (de) 2006-05-04
EP0889727B1 (de) 2006-03-08
HUP9901474A3 (en) 2000-02-28
JP2000506175A (ja) 2000-05-23
PT889727E (pt) 2006-07-31
EP0889727A1 (de) 1999-01-13
WO1997033589A1 (de) 1997-09-18
CA2248841C (en) 2008-07-22
IL126176A0 (en) 1999-05-09
NO984166D0 (no) 1998-09-10

Similar Documents

Publication Publication Date Title
NZ298769A (en) use of progesterone-antagonistic and anti-estrogen compounds in a single dose for female contraception
UA41401C2 (uk) Фармацевтичний контрацептивний комбінований препарат
BR9709934A (pt) Kit de terapia de reposição hormonal e/ou contraceptivo uso de unidades de dosagem diária consistindo essecialmente de um progestogênio e processo de preparação de um sistema de liberação de droga
ES256592U (es) Recipiente de distribucion farmaceutico
DE69319107D1 (de) Pulverabgabevorrichtung für medizinische inhalationstherapien
NL300381I2 (nl) Estradiolvaleraat en dienogest
EE05506B1 (et) Ravimi manustamise vahend eriti progestiinide ja”strogeenide manustamiseks
AU3254395A (en) Use of a combination product that contains a competitive progesterone antagonist and a gestagen for the production of a pharmaceutical agent for treating endometriosis or leiomyomata uteri
CO5261567A1 (es) Uso de sulfamatos estrogenos biogenicos en una terapia de reemplazo de hormonas
EE04997B1 (et) Loteprednooli ja antihistamiinseid aineid sisaldav farmatseutiline kompositsioon, neid aineid sisaldav ravim, meetod selle ravimi valmistamiseks ja nende ainete kombinatsiooni kasutamine
JO2506B1 (en) Dosage titration device in hydrofluoroalkan propellants
NO984166L (no) Sekvenskombinasjon av °strogen/progesteronantagonister for hormonerstatningsterapi
BG101427A (en) Competitive progesterone antagonists for regulating female fertility as required
PL348202A1 (en) Pharmaceutically active composition and dispensing device
DE60025264D1 (de) Dosierbehälter für pulverförmige medikamente
JP2001513566A5 (no)
DE50005282D1 (de) Medikament sowie aufeinander abgestimmte kombination von medikamenten
DK0942729T3 (da) Anvendelse af NK-1-receptorantagonister til behandling af stresslidelser
HUP0104941A2 (hu) Több gyógyszerformát tartalmazó bliszter
HUP9903097A2 (hu) Progesztogén-antiprogesztogén tartalmú gyógyszerkészítmény
AR010296A1 (es) Uso de una combinacion de una progestina y un estrogeno y un equipo anticonceptivo para administracion oral